Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07151339

Acronym

EagleEye3P

Enrollment

100

Registered

2025-09-03

Start date

2024-11-01

Completion date

2030-11-30

Last updated

2025-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia, HELLP Syndrome, Kidney Disease, Preeclampsia

Keywords

cardiovascular prevention, preeclampsia, pregnancy

Brief summary

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* older than 18 yrs * diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy

Exclusion criteria

* unable for informed consent

Design outcomes

Primary

Measure	Time frame
Pulse wave velocity	12 months

Countries

Germany

Contacts

Primary ContactLaura K Sievers, MD

Laura.Rakow@uksh.de+49 431 500 23001

Outcome results